Literature DB >> 22754804

Role of mitomycin-C in prevention of post operative adhesions after endoscopic sinus surgery--a prospective study.

Tilakraj Singh1, Himani Lade, V Natesh.   

Abstract

To evaluate the role of Mitomycin-C in preventing synaechiae formation and ostial stenosis following endoscopic sinus surgery. This prospective study was conducted in VMMC and Safdarjung hospital from November 2007 to August 2008. 30 subjects aged between 16 and 60 of either sex in two groups were included in the study. All these patients with bilateral nasal polyposis underwent endoscopic sinus surgery with topical application of Mitomycin-C and were subjectively and objectively assessed for improvement of symptoms and post operative synaechiae formation. Patients showed improvement in subjective symptoms mainly nasal obstruction and hyposmia as well as decreased incidence of synaechiae formation and ostial stenosis post surgery following Mitomycin-C application. After doing this study we could conclude that Mitomycin-C applied topically following endoscopic sinus surgery was helpful in improvement of symptoms like nasal obstruction and hyposmia as well as decreased adhesion rate and middle meatal antrostomy closure rate. Topical application of Motomycin-C was safe in a dose of 0.4-0.8 mg/ml applied over 5 min and offered significant improvement both subjectively and objectively.

Entities:  

Keywords:  Adhesion rate; Endoscopic sinus surgery; Middle meatal antrostomy closure rate; Mitomycin-C

Year:  2011        PMID: 22754804      PMCID: PMC3138944          DOI: 10.1007/s12070-011-0145-6

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  13 in total

1.  Diagnosis and treatment of uncomplicated acute bacterial rhinosinusitis: summary of the Agency for Health Care Policy and Research evidence-based report.

Authors:  M S Benninger; S E Sedory Holzer; J Lau
Journal:  Otolaryngol Head Neck Surg       Date:  2000-01       Impact factor: 3.497

2.  Middle turbinate medialization technique in functional endoscopic sinus surgery.

Authors:  N Moukarzel; A Nehmé; S Mansour; F G Yammine; A Moukheiber
Journal:  J Otolaryngol       Date:  2000-06

3.  Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study.

Authors:  M A Darzi; N A Chowdri; S K Kaul; M Khan
Journal:  Br J Plast Surg       Date:  1992-07

4.  Surgical causes of failure in endoscopic sinus surgery.

Authors:  H H Ramadan
Journal:  Laryngoscope       Date:  1999-01       Impact factor: 3.325

5.  Advances in postoperative care following functional endoscopic sinus surgery.

Authors:  F A Kuhn; M J Citardi
Journal:  Otolaryngol Clin North Am       Date:  1997-06       Impact factor: 3.346

Review 6.  Acute community-acquired sinusitis.

Authors:  J M Gwaltney
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

7.  Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts.

Authors:  D Hu; B S Sires; D C Tong; G A Royack; D Oda
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2000-03       Impact factor: 1.746

8.  Nasal splints, revisited.

Authors:  D Malki; S M Quine; A G Pfleiderer
Journal:  J Laryngol Otol       Date:  1999-08       Impact factor: 1.469

9.  A new middle meatal antrostomy stent for functional endoscopic sinus surgery.

Authors:  A H Shikani
Journal:  Laryngoscope       Date:  1994-05       Impact factor: 3.325

Review 10.  Epidemiology and economic impact of rhinosinusitis.

Authors:  Vijay K Anand
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  2004-05
View more
  2 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

2.  Mitomycin-C in Post-endoscopic Septoplasty Synechiae: Does it Really Helps?

Authors:  Abu Sayeed; Mehtab Alam; Satish Chandra Sharma; Syed Abrar Hasan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.